Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration.
about
Neuroprotection as a Therapeutic Target for Diabetic RetinopathyLowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activationRatio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease.New Therapeutic Approaches in Diabetic Retinopathy.The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration.Neurodegeneration: An early event of diabetic retinopathy.The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms?Validation of structural and functional lesions of diabetic retinopathy in miceUsefulness of the vitreous fluid analysis in the translational research of diabetic retinopathySelective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.Molecular Implications of the PPARs in the Diabetic Eye.Vitreous levels of somatostatin in patients with chronic uveitic macular oedema.Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediatorsRetinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterationsDiabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes.Animal models of diabetic retinopathy: summary and comparison.IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling.Somatostatin protects photoreceptor cells against high glucose-induced apoptosis.Neuroprotection in diabetic retinopathy.Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives.Vitreous humor in the pathologic scope: insights from proteomic approaches.Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents.Diabetic retinopathy is a neurodegenerative disorder.Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes MellitusDiabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.Diabetic retinopathy: current understanding, mechanisms, and treatment strategiesEffects of minocycline on expression of bcl-2, bax in early retinal neuropathy of diabetes in ratsProapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy.Protective effects of Purendan superfine powder on retinal neuron apoptosis in a rat model of type 2 diabetes mellitus.Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.Diabetic retinopathy: research to clinical practice.Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats.Flavonoid Naringenin Attenuates Oxidative Stress, Apoptosis and Improves Neurotrophic Effects in the Diabetic Rat Retina.Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose.Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.Macular thinning in prediabetes or type 2 diabetes without diabetic retinopathy: the Maastricht Study.Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy.Magnetic resonance imaging retinal oximetry: a quantitative physiological biomarker for early diabetic retinopathy?Effect of fenofibrate on retinal neurodegeneration in an experimental model of type 2 diabetes
P2860
Q26749178-DE82170B-95DF-4244-91F1-B82D6E93B818Q33360791-E96036AD-D228-48F1-9F71-B5DF78AD8D3EQ33575064-A7784037-1340-44FB-B886-B6AD97AAF242Q33583037-82EF9000-E4FB-4094-8003-32593B056A93Q33623614-272052F5-19C3-4148-A448-E264A921D586Q33887925-31437788-DEC7-466B-A309-5CC29E93E95BQ34100527-02EE30B3-662C-4E63-9485-875DF672E103Q34109492-5D53E5D4-4172-466A-8F52-D437C76D0600Q34364177-E75E4402-4D47-4CBF-92F9-FC9AE44153C3Q34426246-8D027D1F-ADF8-4913-A0CD-C003CFE39E11Q34554602-817C81F4-5325-4E25-818A-6AEFE06A97D0Q34594935-3F4B2476-5585-4248-B2EC-1E23441863CDQ36313749-C45DB2EA-9C2B-44D3-8C69-40F5047DE8F0Q36756478-825CB63E-9EE1-4D84-A840-6940D5455C1EQ36960107-8BB0C19C-61A4-4708-94A7-F0255D94F43AQ37193753-F29CF1E1-C857-4B31-9D47-EFD94AC543A4Q37304677-6238EB4A-DDD8-4155-8C0C-0A58C55F2FE6Q37538552-04580764-518F-49F1-A634-0E7DCFDD0E3AQ37548629-91D1BC25-89E3-47D8-906D-512E951A6BB1Q38009713-F133269A-1478-490D-BFD5-F453F336EAE8Q38195792-4C0F9B2D-856B-4383-AAB6-2AC2B86475F7Q38293676-E676B507-8FD6-48E4-AA71-FFA21A169D10Q38715502-986F20C4-BA4E-47D5-BEC3-DD904AC2AF24Q38730604-C9BB91F9-7F91-4720-BDBE-297C2AA50045Q38928508-6CF92C4C-9D84-47BC-8998-E18F5352DC3FQ39208422-BD6D24D7-2E8F-4229-83D3-883886BA4714Q39445950-53E07A27-C05B-4A28-8FFA-AD27904EAAE7Q41779906-2868C02E-7B15-4C46-A6B7-324780E835CBQ41897000-6F3FCF10-D92A-4054-B1A2-F09A0160B105Q41945449-47E146AD-980A-44CB-AED8-5D933EBDCF01Q42084102-23FE0F9F-59FB-48DF-894D-BD5014432EA9Q42672190-A508AD4A-C96C-4D1B-8EFD-A70A215E6917Q42733746-8128EED0-38E7-49DB-9D2A-FCF6C2282D37Q46500518-BD180A7B-9D78-4C38-97A2-CB395531AE29Q47951826-5CB921F8-0DE4-4880-9306-3196E22D8ADBQ47988627-A619C787-6819-495E-93BE-FF315A538701Q48090307-9FC49BAD-208A-4446-B442-2A909A625092Q48099809-FAAAB628-0B0C-4BB5-A25D-BAFDA96F0744Q53202921-F409EFF0-0F00-425F-B503-4331F1CB5A36Q58461756-B95A2579-5DF1-411A-91B0-2B98FE3F031D
P2860
Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lower somatostatin expression ...... ith retinal neurodegeneration.
@ast
Lower somatostatin expression ...... ith retinal neurodegeneration.
@en
type
label
Lower somatostatin expression ...... ith retinal neurodegeneration.
@ast
Lower somatostatin expression ...... ith retinal neurodegeneration.
@en
prefLabel
Lower somatostatin expression ...... ith retinal neurodegeneration.
@ast
Lower somatostatin expression ...... ith retinal neurodegeneration.
@en
P2093
P356
P1433
P1476
Lower somatostatin expression ...... ith retinal neurodegeneration.
@en
P2093
Adela Miralles
Cristina Hernández
Esther Carrasco
Jaume Farrés
Pere Huguet
Rafael Simó
P304
P356
10.2337/DC07-0332
P407
P50
P577
2007-08-17T00:00:00Z